Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors
Published: April 08, 2019
- This statement introduces the concept of cardio-oncology rehabilitation, which is important for the more than 16.7 million cancer survivors in the US – all at increased risk of morbidity and mortality from non-cancer causes, predominately cardiovascular disease (CVD).
- Cancer survivors and patients with early-stage cancer are more susceptible to CVD because of the effects of both their cancer and cancer treatments.
- This statement presents a targeted approach to identifying patients with cancer who are likely to get the greatest benefit from cardiac rehabilitation.
Supporting Materials
Recommended Reading
- Cardio-Oncology: Vascular and Metabolic Perspectives
- Cardiovascular Disease and Breast Cancer: Where These Entities Intersect
- 2018 ACC/AHA Clinical Performance and Quality Measures for Cardiac Rehabilitation
- Executive Summary: 2017 Hypertension Clinical Guidelines
- Routine Assessment and Promotion of Physical Activity in Healthcare Settings
- Increasing Referral and Participation Rates to Outpatient Cardiac Rehabilitation: The Valuable Role of Healthcare Providers in the Inpatient and Home Health Settings
- Referral, Enrollment and Delivery of Cardiac Rehabilitation/Secondary Prevention Programs at Clinical Centers and Beyond